欧洲和北美Graves病治疗策略浅谈(3)
 |
| 第1页 |
参见附件。
[13] Reinwein D, Benker G, Konig MP,et,al. Radioiodine therapy in Graves disease based on tissue-absorbed dose calculations: effect of pre-treatment thyroid volume on clinical outcome[J].Eur J Nucl Med Mol Imaging,2005,29:1118-1124.
[14] Kendall-Taylor P, Keir MJ, Ross VM. Ablative radioiodine therapy for hyperthyroidism: A long-term follow-up study[J].Br Med J(Clinical research ed),1984,289:361-363.
[15] Palit TK, Miller CC, Miltenburg DM. The efficacy of thyroidectomy for Graves disease: A meta-analysis[J]. J Surg Res,2010,90:161-165.
[16] K.Miehle, R.Paschke. Therapy of Hyperthyroidism[J]. Exp Clin Endocrinol Diabetes,2003,111:305-318.
[17] Anonymous. American Association of Clinical Endocrinologists release clinical guidelines for thyroid disease[J]. Am Fam Physician,1995,51:679-680.
[18] Singer PA, Cooper DS, Levy EG,et,al.Treatment guidelines for patients with hyperthyroidism and hypothyroidism.Standards of Care Committee, American Thyroid Association[J]. JAMA, 2009,273:808-812.
(收稿日期：2011-10-18)
(本文编辑：陈丹云)
您现在查看是摘要介绍页，详见PDF附件。